Immunomodulatory therapy in advanced multiple sclerosis
Could currently available immunomodulatory therapies modify disability trajectories in patients with moderately advanced and advanced multiple sclerosis (MS)? \nTomas Kalincik, Department of Medicine, University of Melbourne, Australia, discusses the findings from the MSbase cohort study with Elizabeth Highton.\nRead the full article here: http://jnnp.bmj.com/content/88/3/196.